Serum irisin levels are regulated by acute strenuous exercise

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 4, 2015, Pages 1289-1299

  Löffler, Dennis ^a   Müller, Ulrike ^b   Scheuermann, Kathrin ^a   Friebe, Daniela ^a   Gesing, Julia ^a   Bielitz, Julia ^a   Erbs, Sandra ^b   Landgraf, Kathrin ^a   Wagner, Isabel Viola ^a   Kiess, Wieland ^a   Körner, Antje ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; IRISIN; MUSCLE PROTEIN; UNCLASSIFIED DRUG; FIBRONECTIN; FNDC5 PROTEIN, HUMAN; HYDROCORTISONE;

ADOLESCENT; ADULT; AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BICYCLE ERGOMETRY; CHILD; CIRCADIAN RHYTHM; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CORRELATION ANALYSIS; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE INTENSITY; FAT FREE MASS; FEMALE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MUSCLE MASS; NORMAL HUMAN; NUTRITIONAL COUNSELING; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SEX DIFFERENCE; TIME; VOLUNTEER; BLOOD; CONTROLLED CLINICAL TRIAL; DRUG EFFECTS; EXERCISE; MEAL; METABOLOME; PEDIATRIC OBESITY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CIRCADIAN RHYTHM; EXERCISE; FEMALE; FIBRONECTINS; GLUCOSE; HUMANS; HYDROCORTISONE; MALE; MEALS; METABOLOME; PEDIATRIC OBESITY; PHYSICAL EXERTION; SEX FACTORS; YOUNG ADULT;

EID: 84927625981     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2932     Document Type: Article

References (37)

1. Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463-468.
2. Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013;98:E769-E778.
3. Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metab Clin Exp. 2012;61:1725-1738.
4. Kurdiova T, Balaz M, Vician M, et al. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol (Lond). 2014;592:1091-1107.
5. Aydin S, Aydin S, Kuloglu T, et al. Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running. Peptides. 2013;50:13-18.
6. Dun SL, Lyu RM, Chen YH, Chang JK, Luo JJ, Dun NJ. Irisinimmunoreactivity in neural and non-neural cells of the rodent. Neuroscience. 2013;240:155-162.
7. Roca-Rivada A, Castelao C, Senin LL, et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One. 2013;8:e60563.
8. Norheim F, Langleite TM, Hjorth M, et al. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans. FEBS J. 2014;281:739-749.
9. Brenmoehl J, Albrecht E, Komolka K, et al. Irisin is elevated in skeletal muscle and serum of mice immediately after acute exercise. Int J Biol Sci. 2014;10:338-349.
10. Kraemer RR, Shockett P, Webb ND, Shah U, Castracane VD. A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women. Horm Metab Res. 2014;46:150-154.
11. Lawson EA, Ackerman KE, Slattery M, et al. Oxytocin secretion is related to measures of energy homeostasis in young amenorrheic athletes. J Clin Endocrinol Metab. 2014;99:E881-E885.
12. Besse-Patin A, Montastier E, Vinel C, et al. Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine. Int J Obes (Lond). 2014;38:707-713.
13. Pekkala S, Wiklund PK, Hulmi JJ, et al. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J Physiol (Lond). 2013;591:5393-5400.
14. Raschke S, Elsen M, Gassenhuber H, et al. Evidence against a beneficial effect of irisin in humans. PLoS One. 2013;8:e73680.
15. Crujeiras AB, Pardo M, Arturo R, et al. Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women. Am J Hum Biol. 2014;26:198-207.
16. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides. 2013;39:125-130.
17. Park KH, Zaichenko L, Peter P, Davis CR, Crowell JA, Mantzoros CS. Diet quality is associated with circulating C-reactive protein but not irisin levels in humans. Metab Clin Exp. 2014;63:233-241.
18. Sanchis-Gomar F, Lippi G, Mayero S, Perez-Quilis C, García-Giménez JL. Irisin: a new potential hormonal target for the treatment of obesity and type 2 diabetes. J Diabetes. 2012;4:196.
19. Liu JJ, Wong MD, Toy WC, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications. 2013;27:365-369.
20. Kromeyer-Hauschild K, Wittchen H. Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Dresden: Technische Universität Dresden; 2001.
21. Friebe D, Neef M, Kratzsch J, et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyl transferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia. 2011;54:1200-1211.
22. Walther C, Adams V, Bothur I, et al. Increasing physical education in high school students: effects on concentration of circulating endothelial progenitor cells. Eur J Cardiovasc Prev Rehabil. 2008;15:416-422.
23. Zhang Y, Li R, Meng Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes. 2014;63:514-525.
24. Choi HY, Kim S, Park JW, et al. Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans. J Clin Endocrinol Metab. 2014;99:2778-2785.
25. Yu H, Xia F, Lam KS, et al. Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans. Clin Chem. 2011;57:691-700.
26. Anastasilakis AD, Polyzos SA, Saridakis ZG, et al. Circulating irisin in healthy, young individuals: day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition. J Clin Endocrinol Metab. 2014;99:3247-3255.
27. Coppari R, Ramadori G, Elmquist JK. The role of transcriptional regulators in central control of appetite and body weight. Nat Clin Pract Endocrinol Metab. 2009;5:160-166.
28. Sesti G, Andreozzi F, Fiorentino TV, et al. High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects. Acta Diabetol. 2014;51:705-713.
29. Blüher S, Panagiotou G, Petroff D, et al. Effects of a 1-year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children. Obesity (Silver Spring). 2014;22:1701-1708.
30. Sanchis-Gomar F, Alis R, Pareja-Galeano H, Romagnoli M, Perez-Quilis C. Inconsistency in circulating irisin levels: what is really happening? Horm Metab Res. 2014;46:591-596.
31. Al-Daghri NM, Alkharfy KM, Rahman S, et al. Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects. Eur J Clin Invest. 2014;44:119-124.
32. Pardo M, Crujeiras AB, Amil M, et al. Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. Int J Endocrinol. 2014;2014:857270.
33. Talluri A, Liedtke R, Mohamed EI, Maiolo C, Martinoli R, Lorenzo A de. The application of body cell mass index for studying muscle mass changes in health and disease conditions. Acta Diabetol. 2003;40(suppl 1):S286-S289.
34. Dörhöfer RP, Pirlich M. Das BIA-Kompendium, 3rd ed. Darmstadt, Germany: Data Input; 2005. www.data-input.de/media/pdf-deutsch/Kompendium-III-Ausgabe-2009.pdf.
35. Schumacher MA, Chinnam N, Ohashi T, Shah RS, Erickson HP. The structure of irisin reveals a novel intersubunit β-sheet fibronectin type III (FNIII) dimer: implications for receptor activation. J Biol Chem. 2013;288:33738-33744.
36. Raschke S, Eckel J. Adipo-myokines: two sides of the same coin-mediators of inflammation and mediators of exercise. Mediators Inflamm. 2013;2013:320724.
37. Catoire M, Mensink M, Kalkhoven E, Schrauwen P, Kersten S. Identification of human exercise-induced myokines using secretome analysis. Physiol Genomics. 2014;46:256-267.